Vaccines and Public Health

Adult immunization rates are falling short of national targets. Learn how global, federal, and state policies affect vaccination uptake. Leverage our findings to guide your strategies. Rely on our expertise commercializing novel and therapeutic vaccines.

Mitchell Finkel

Podcast: RSV Prevention, Part I: Pediatric Monoclonal Antibodies

Tune into the first episode in our video series focused on Respiratory Syncytial Virus (RSV) prevention. In this segment, Avalere experts discuss how innovative offerings in the pediatric RSV immunization market will fit within the continuum of care and how the RSV preventive market will grow in the upcoming years.

Elif Alyanak

Navigating the Road to RSV Prevention

Numerous novel respiratory syncytial virus (RSV) preventive products, including vaccines and monoclonal antibodies (mAbs), are in late-stage clinical development. Consequently, the RSV prevention landscape is expected to transform in the coming years. Adequate preparation to incorporate the use of these new tools should consider the regulatory and recommendation pathways and their implications for coverage and reimbursement.

Comparing Medicare FFS Pneumococcal Vaccination Rates in 2019 and 2020

A new study from Avalere analyzes age, race and ethnicity, and Medicare-Medicaid dual-eligibility status of Medicare Fee-For-Service (FFS) beneficiaries with pneumococcal vaccine claims in 2019 and 2020.

Mali Khan

Addressing Climate Change Impacts on Health

As climate change continues to alter the patterns of everyday life, healthcare stakeholders should consider strategies to prevent and mitigate negative environmental contributions and proactively address the impacts of climate change on health outcomes, health equity, and healthcare costs.

Massey Whorley

Microarray Patches Could Improve Pandemic Vaccination

The rollout of COVID-19 vaccines highlights the need for continued innovation in how vaccines are delivered.

Mali Khan

Midlife Prevention of Alzheimer’s Disease

Although Alzheimer’s disease has no known cure, recent evidence points to several advancements that may enhance the understanding of the progression of the disease.

Haley Payne

Declines in Routine Adult and Teen Vaccinations Continued in 2021

Updated Avalere analysis shows that routine immunization continued to lag in 2021 below pre-pandemic levels, highlighting the continuing effect of COVID-19 on routine vaccination.

Christie Teigland

Study Examines the Impact of Healthy Aging Programs on Health Outcomes

Avalere conducted a retrospective observational analysis to examine differences in healthcare outcomes among Medicare beneficiaries enrolled in Medicare Advantage (MA) and participating in the Silver Sneakers healthy aging program.

Avalere Research Highlights Alternative Settings for Vaccination

The CDC recommends HBV vaccinations for persons with a history of current or recent injection drug use, but uptake remains low. Avalere research shows an opportunity to leverage alternative care settings to address the growing rates of HBV infection.

Vaccination Rates Among Medicaid Adolescents Declined During Pandemic

A new claims-based analysis from Avalere examined vaccine uptake among low-income adolescents enrolled in Medicaid Managed Care and found a 26% decline in routine vaccinations when comparing March–October 2019 to the same period in 2020.

Kelly George

Considerations for a Shift from Pandemic to Endemic COVID-19 Landscape

Stakeholders in the COVID-19 pandemic response face regulatory and commercial uncertainties as emergency operations transition and market access of products face both emergency use and full licensure.

Self-Administered Vaccines Present Broad Opportunities

The COVID-19 pandemic response has increased investment in vaccine innovations, but also exposed gaps in US and global vaccine access and delivery.

Webinar: Post-Pandemic Planning for Life Sciences Companies

Avalere’s data analytics and market access experts will be joined by Jeff Patton, MD and CEO of OneOncology, to explore critical issues and considerations for life sciences stakeholders following the pandemic.

Updated Analysis Finds Sustained Drop in Routine Vaccines Through 2020

In 2020, the COVID-19 pandemic resulted in nationwide lockdowns and restrictions with a well-documented impact on utilization of routine healthcare services.

Melissa Morley

Accurate COVID-19 Testing to Protect the Military and Support Schools

The US continues to face challenges with managing COVID-19 (SARS-CoV-2) while reopening communities. Accurate COVID-19 diagnostic testing is an effective tool in minimizing the risk of transmission.

Kelly George

Avalere Statement on US Support of TRIPS Waiver for COVID Vaccines

On May 5, the Biden administration announced its support for waiving World Trade Organization (WTO) intellectual property regulations with respect to COVID-19 vaccines, in an effort to increase supply and worldwide access to the vaccines.

Sign up to receive more insights about Vaccines and Public Health
Please enter your email address to be notified when new Vaccines and Public Health insights are published.

Back To Top